1. Home
  2. Business
  3. CBI alleges fraud against Gupta brothers, founders of Ashoka University

CBI alleges fraud against Gupta brothers, founders of Ashoka University

By Ruchi Upadhyay 
Updated Date
CBI alleges fraud against Gupta brothers, founders of Ashoka University

New Delhi: Ashoka University co-founders Pranav Gupta and Vineet Gupta have been charged by the CBI for allegedly duping a Chandigarh-based pharmaceutical company Parabolic Drugs to the tune of Rs 1,626 crore.

Also Read :- CBI arrests GAIL director in a bribery case, recovers 1.30 crore in raid

The CBI has registered a case against the company, Pranav Gupta, Vineet Gupta, and 10 others. They are accused of cheating the Central Bank of India and 11 other banks. The Guptas were raided in multiple cities on December 31.

Incriminating documents, articles and ₹ 1.58 crore cash were found in the raids, the CBI says. The Gupta brothers face charges like criminal conspiracy and forgery.

The Ashoka University website shows Vineet Gupta as the founder and trustee and Pranav Gupta as the co-founder and trustee. Parabolic Drugs, promoted by the Gupta brothers, was set up in 1996. It manufactures drugs and drugs intermediaries.

The CBI is inquiring into allegations that Parabolic used forged documents to secure loan from the State Bank of India, UCO Bank, State Bank of Patiala, ICICI Bank, IDBI Bank, State Bank of Hyderabad, Central Bank of lndia, Union Bank of India, Bank of Baroda, Exim Bank, Canara Bank and SIDBI.

Also Read :- CBI to prosecute former Allahabad HC judge SN Shukla in 'bribery' case

The CBI’s FIR, based on the Central Bank of India’s complaint, says the company has defaulted on repayment since 2012. “The company availed bank finance by overstating the value of primary security against which drawings were allowed by the bank,” says the complaint.

“After having conspired to induce the banks to sanction the funds under the cover of their business needs, the accused deployed devious tactics to mis-utilise the funds and siphon/divert the said funds to avoid repayment and/or personally enrich themselves and thereby causing losses to the banks,” it says.

In 2014, the State Bank classified the accounts of Parabolic Drugs as “Non Performing Assets”. The Central Bank of India followed soon after.

Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...